These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9342178)

  • 1. Experimental models for evaluating enzyme induction potential of new drug candidates in animals and humans and a strategy for their use.
    Thompson TN
    Adv Pharmacol; 1997; 43():205-29. PubMed ID: 9342178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction.
    Li AP; Maurel P; Gomez-Lechon MJ; Cheng LC; Jurima-Romet M
    Chem Biol Interact; 1997 Nov; 107(1-2):5-16. PubMed ID: 9402946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time to move cytochrome p450 induction into mainstream pharmacology is long overdue.
    Smith DA; Dickins M; Fahmi OA; Iwasaki K; Lee C; Obach RS; Padbury G; De Morais SM; Ripp SL; Stevens J; Voorman R; Youdim K
    Drug Metab Dispos; 2007 Apr; 35(4):697-8. PubMed ID: 17384203
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening of drug candidates for their drug--drug interaction potential.
    Rodrigues AD; Lin JH
    Curr Opin Chem Biol; 2001 Aug; 5(4):396-401. PubMed ID: 11470602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system.
    Paine AJ
    Chem Biol Interact; 1990; 74(1-2):1-31. PubMed ID: 2182201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes.
    Yuan J; Liu L; Shimada M; Wang A; Ruhnke M; Heeckt P; Muller AR; Nussler NC; Neuhaus P; Nussler A
    ALTEX; 2004; 21 Suppl 3():3-11. PubMed ID: 15057403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approaches.
    Grime K; Ferguson DD; Riley RJ
    Curr Drug Metab; 2010 Dec; 11(10):870-85. PubMed ID: 21208171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytochrome P450 enzymes: a view on human in vivo findings.
    Hukkanen J
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):569-85. PubMed ID: 23121279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme induction: translating multiple approaches, assays, endpoints, and opinions into a valuable induction screening strategy.
    Fretland A; Monshouwer M
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):135-44. PubMed ID: 20053161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
    Li AP; Reith MK; Rasmussen A; Gorski JC; Hall SD; Xu L; Kaminski DL; Cheng LK
    Chem Biol Interact; 1997 Nov; 107(1-2):17-30. PubMed ID: 9402947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and induction of human cytochrome P450 enzymes: current status.
    Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
    Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole induction of cytochrome P-450IA2: the importance of selecting the appropriate human model.
    Watkins PB
    Hepatology; 1993 Apr; 17(4):748-50. PubMed ID: 8477980
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes.
    Tanaka E
    J Clin Pharm Ther; 1998 Dec; 23(6):403-16. PubMed ID: 10048501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes.
    Masubuchi N; Li AP; Okazaki O
    Chem Biol Interact; 1998 Jul; 114(1-2):1-13. PubMed ID: 9744552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative reverse transcriptase/PCR assay for the measurement of induction in cultured hepatocytes.
    Mattes WB; Li AP
    Chem Biol Interact; 1997 Nov; 107(1-2):47-61. PubMed ID: 9402949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes.
    Clark MA; Bing BA; Gottschall PE; Williams JF
    Biochem Pharmacol; 1995 Jan; 49(1):97-104. PubMed ID: 7840789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-automatic quantitative RT-PCR to measure CYP induction by drugs in human hepatocytes.
    Pérez G; Tabares B; Jover R; Gómez-Lechón MJ; Castell JV
    Toxicol In Vitro; 2003; 17(5-6):643-9. PubMed ID: 14599457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions.
    Li AP
    Adv Pharmacol; 1997; 43():103-30. PubMed ID: 9342174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.